InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.74
(
1.03%
)
US TECH 100
17,610.00
(
0.00%
)
Dow Jones
38,852.27
(
0.46%
)
Brent Oil
83.25
(
-0.28%
)
Bitcoin
63,807.30
(
1.02%
)
Post# of 91007
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

hen81

Send PM Follow Ignore
Followers 5
Posts 173
Boards Moderated 0
Alias Born 01/26/2014

hen81

Re: None

Sunday, 09/21/2014 1:12:09 PM

Sunday, September 21, 2014 1:12:09 PM

Post# of 91007
SVFC...good news
The US Food and Drug Administration (FDA) today approved Movantik (naloxegol), an oral peripherally acting mu-opioid receptor antagonist, for the treatment of opioid-induced constipation (OIC) in adults with chronic non-cancer pain.
See more at: http://www.hcplive.com/articles/FDA-Approves-Movantik-for-the-Treatment-of-Opioid-induced-Constipation?sao=31&utm_source=outBrain&utm_medium=HCPLive&utm_campaign=Pain%20Management#sthash.AV73L7jy.dpuf


http://www.hcplive.com/articles/FDA-Approves-Movantik-for-the-Treatment-of-Opioid-induced-Constipation?sao=31&utm_source=outBrain&utm_medium=HCPLive&utm_campaign=Pain%20Management
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up